Pimagedine
- Generic Name
- Pimagedine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- CH6N4
- CAS Number
- 79-17-4
- Unique Ingredient Identifier
- SCQ4EZQ113
- Background
Pimagedine has been developed by Synvista Therapeutics, Inc for the treatment of diabetic kidney disease. It is an advanced glycation end product inhibitor which manages diabetic nephropathy, either alone or in combination with other therapies. It is beneficial in treating patients with diabetic nephropathy.
- Indication
Investigated for use/treatment in diabetic kidney disease.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath